SYT13 gene therapy targeted to vulnerable motor neurons prolonged the lifespan of SOD1G93A ALS mice as well as spinal muscular atrophy (SMA) mice, by protecting the neurons and rescuing their connectivity with muscle (Fig. 2B). This evidence concerns the gene SYT13 and proximal spinal muscular atrophy.